ICUI Quote, Financials, Valuation and Earnings

Becton Dickinson & has a net margin of -5.6% compared to ICU Medical's net margin of 7.36%. ICU Medical's return on equity of -5.35% beat Becton Dickinson &'s return on equity of 6.63%.

ICU Medical has a consensus price target of $142.25, signalling upside risk potential of 30%. On the other hand Becton Dickinson & has an analysts' consensus of $280.03 which suggests that it could grow by 22.56%. Given that ICU Medical has higher upside potential than Becton Dickinson &, analysts believe ICU Medical is more attractive than Becton Dickinson &.

ICU Medical has a beta of 0.623, which suggesting that the stock is 37.74% less volatile than S&P 500. In comparison Becton Dickinson & has a beta of 0.408, suggesting its less volatile than the S&P 500 by 59.216%.

ICU Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Becton Dickinson & offers a yield of 1.7% to investors and pays a quarterly dividend of $1.04 per share. ICU Medical pays -- of its earnings as a dividend. Becton Dickinson & pays out 64.52% of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

ICU Medical quarterly revenues are $589.1M, which are smaller than Becton Dickinson & quarterly revenues of $5.4B. ICU Medical's net income of -$33M is lower than Becton Dickinson &'s net income of $400M. Notably, ICU Medical's price-to-earnings ratio is -- while Becton Dickinson &'s PE ratio is 38.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical is 1.62x versus 3.29x for Becton Dickinson &. Usually stocks with elevated PS ratios are considered overvalued.

Perspective Therapeutics has a net margin of -5.6% compared to ICU Medical's net margin of --. ICU Medical's return on equity of -5.35% beat Perspective Therapeutics's return on equity of --.

ICU Medical has a consensus price target of $142.25, signalling upside risk potential of 30%. On the other hand Perspective Therapeutics has an analysts' consensus of $16.15 which suggests that it could grow by 390.88%. Given that Perspective Therapeutics has higher upside potential than ICU Medical, analysts believe Perspective Therapeutics is more attractive than ICU Medical.

ICU Medical has a beta of 0.623, which suggesting that the stock is 37.74% less volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.129, suggesting its more volatile than the S&P 500 by 12.894%.

ICU Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical pays -- of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend.

ICU Medical quarterly revenues are $589.1M, which are larger than Perspective Therapeutics quarterly revenues of --. ICU Medical's net income of -$33M is lower than Perspective Therapeutics's net income of -$15.1M. Notably, ICU Medical's price-to-earnings ratio is -- while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical is 1.62x versus 17.77x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision has a net margin of -5.6% compared to ICU Medical's net margin of -4291.67%. ICU Medical's return on equity of -5.35% beat Catheter Precision's return on equity of -65.84%.

ICU Medical has a consensus price target of $142.25, signalling upside risk potential of 30%. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 377.33%. Given that Catheter Precision has higher upside potential than ICU Medical, analysts believe Catheter Precision is more attractive than ICU Medical.

ICU Medical has a beta of 0.623, which suggesting that the stock is 37.74% less volatile than S&P 500. In comparison Catheter Precision has a beta of -0.210, suggesting its less volatile than the S&P 500 by 121.025%.

ICU Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

ICU Medical quarterly revenues are $589.1M, which are larger than Catheter Precision quarterly revenues of $96K. ICU Medical's net income of -$33M is lower than Catheter Precision's net income of -$4.1M. Notably, ICU Medical's price-to-earnings ratio is -- while Catheter Precision's PE ratio is 0.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical is 1.62x versus 1.12x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings has a net margin of -5.6% compared to ICU Medical's net margin of -17.98%. ICU Medical's return on equity of -5.35% beat Xtant Medical Holdings's return on equity of -35.98%.

ICU Medical has a consensus price target of $142.25, signalling upside risk potential of 30%. On the other hand Xtant Medical Holdings has an analysts' consensus of -- which suggests that it could grow by 418.19%. Given that Xtant Medical Holdings has higher upside potential than ICU Medical, analysts believe Xtant Medical Holdings is more attractive than ICU Medical.

ICU Medical has a beta of 0.623, which suggesting that the stock is 37.74% less volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of 0.357, suggesting its less volatile than the S&P 500 by 64.342%.

ICU Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. ICU Medical pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

ICU Medical quarterly revenues are $589.1M, which are larger than Xtant Medical Holdings quarterly revenues of $27.9M. ICU Medical's net income of -$33M is lower than Xtant Medical Holdings's net income of -$5M. Notably, ICU Medical's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ICU Medical is 1.62x versus 0.51x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.